Request for a preliminary ruling from the Conseil d’État (France) lodged on 5 April 2014 — Pierre Fabre Médicament v Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé

(Case C-273/14)

2014/C 282/29

Language of the case: French

Referring court

Conseil d’État

Parties to the main proceedings

Applicant: Pierre Fabre Médicament

Defendants: Ministre du Budget, des Comptes Publics et de la Réforme de l’État, Ministre des Affaires Sociales et de la Santé

Question referred

Do points 3 and 5 of Article 6 of Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems (1) apply to decisions removing a proprietary product from the list of medicinal products administered to inpatients in health establishments that may be covered by compulsory health insurance schemes in addition to hospital treatments covered in the context of fixed payments for stays and care determined by diagnosis related group?

(1)  OJ 1989 L 40, p. 8.